Telavancin May Require Informed Consent For Women Of Childbearing Age
This article was originally published in The Pink Sheet Daily
Executive Summary
The Anti-Infective Drugs Advisory Committee will consider whether a REMS is necessary given the teratogenic risks of Theravance’s antibiotic.